Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.